Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125641952 | 12564195 | 2 | F | 20160524 | 20160707 | 20160718 | 20160919 | EXP | PHHY2016FR075389 | NOVARTIS | 71.05 | YR | M | Y | 105.00000 | KG | 20160920 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125641952 | 12564195 | 1 | PS | TAFINLAR | DABRAFENIB MESYLATE | 1 | Oral | UNK | 202806 | ||||||||||
| 125641952 | 12564195 | 2 | SS | TAFINLAR | DABRAFENIB MESYLATE | 1 | Oral | UNK | 202806 | ||||||||||
| 125641952 | 12564195 | 3 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 125641952 | 12564195 | 4 | SS | PREVISCAN | FLUINDIONE | 1 | Oral | UNK | 0 | ||||||||||
| 125641952 | 12564195 | 5 | SS | PREVISCAN | FLUINDIONE | 1 | 0 | ||||||||||||
| 125641952 | 12564195 | 6 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 125641952 | 12564195 | 7 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125641952 | 12564195 | 8 | C | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 125641952 | 12564195 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125641952 | 12564195 | 10 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 125641952 | 12564195 | 11 | C | BISOPROLOL | BISOPROLOL | 1 | U | 0 | |||||||||||
| 125641952 | 12564195 | 12 | C | BISOPROLOL | BISOPROLOL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125641952 | 12564195 | 1 | Metastatic malignant melanoma |
| 125641952 | 12564195 | 3 | Hypertension |
| 125641952 | 12564195 | 4 | Arrhythmia |
| 125641952 | 12564195 | 5 | Atrial fibrillation |
| 125641952 | 12564195 | 6 | Dyslipidaemia |
| 125641952 | 12564195 | 7 | Hypertension |
| 125641952 | 12564195 | 8 | Diabetes mellitus |
| 125641952 | 12564195 | 9 | Pain |
| 125641952 | 12564195 | 10 | Hypertension |
| 125641952 | 12564195 | 11 | Arrhythmia |
| 125641952 | 12564195 | 12 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125641952 | 12564195 | OT |
| 125641952 | 12564195 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125641952 | 12564195 | Immune thrombocytopenic purpura | |
| 125641952 | 12564195 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125641952 | 12564195 | 1 | 201410 | 20160524 | 0 | |
| 125641952 | 12564195 | 2 | 20160531 | 0 | ||
| 125641952 | 12564195 | 3 | 2013 | 20160524 | 0 | |
| 125641952 | 12564195 | 4 | 2013 | 20160524 | 0 | |
| 125641952 | 12564195 | 6 | 2013 | 20160524 | 0 | |
| 125641952 | 12564195 | 7 | 2013 | 0 | ||
| 125641952 | 12564195 | 8 | 2015 | 0 | ||
| 125641952 | 12564195 | 9 | 2005 | 0 | ||
| 125641952 | 12564195 | 10 | 2013 | 0 |